Research Library

By Anshul Bhatnagar, Jingbo Niu, Vivian Ho, Wolfgang C. Winkelmayer and Kevin Erickson

Recent initiatives aim to improve…

By Kevin F. Erickson, Melandrea Worsley and Wolfgang C. Winkelmayer

Fifty years ago, on October 30, then-President…

Observations that peritoneal dialysis (PD) may be an effective, lower-cost alternative to hemodialysis for the treatment of ESKD have led to policies encouraging PD and subsequent increases in its use in the United States.

In a study for the British Journal of Political Science, the authors found that Muslim religious leaders weaken their perceived religious authority when they engage with politics.

Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).

The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004

The authors assess the impact of Mexico's 2014 energy reform on consumer welfare.

It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.

This study leverages validated patient-reported outcomes measures  to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons